The Intersection of Cardiovascular Prevention in Coronary Imaging

An introduction to the utility and promise of plaque imaging in CAD prevention.

Deepak L. Bhatt

MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Director, Mount Sinai Fuster Heart Hospital; Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine, Mount Sinai

What is a Cleerly analysis?

An introduction and review of the Cleerly AI software analysis, including an interactive demonstration of plaque analysis and reporting.

James Earls

MD, FSCCT

Chief Medical Officer, Cleerly; Professor of Radiology, George Washington University School of Medicine

Real World Experience – Symptomatic Patients, CERTAIN Data

A review of the clinical utility of Cleerly's software suite and how it is integrated into the care of symptomatic patients.

Matthew Budoff

Professor of Medicine, UCLA; Endowed Chair of Preventive Cardiology, Lundquist Institute

Cleerly ISCHEMIA: Validation and Clinical Application in Chest Pain Patients

A value-based assessment of chest pain combining stenosis, atherosclerosis and ischemia enabling a validated, high value, guideline assessment of CAD.

Andrew Choi

MD, FACC, MSCCT

Co-Director of Multimodality Cardiac Imaging and Associate Professor, George Washington University School of Medicine

Understanding Cleerly Coding for Billing

A review of the available CPT codes for both plaque analysis and ischemia analysis as well as payment and reimbursement considerations.

Katharine L. Krol

MD, FSIR, FACR, RCCIR

Consultant; Past President, Society of Interventional Radiology; Member, Digital Medicine Payment Advisory Group, AMA

Plaque, Stenosis, & Ischemia: How does it all fit together? A new approach for all users.

An overview of how a comprehensive approach to assessing plaque, stenosis, and ischemia is transforming CAD evaluation.

Maros Ferencik

Professor of Medicine and Radiology, Cardiologist and Cardiac Imager, Oregon Health & Science University

Cleerly CAD Platform: Minneapolis Heart Institute Experience

An inside look at how the Minneapolis Heart Institute is integrating Cleerly’s platform into clinical practice.

Victor Cheng

Staff Physician, Cardiology and Cardiac Imaging, Cedars-Sinai Medical Center

The AI’s Have It! Quantitative Plaque Analysis as a Therapeutic Modulator

An introduction to AI-driven plaque analysis and its potential role in guiding therapeutic strategies.

John A. Osbourne

MD, PhD, FACC, FNLA

Preventive and Consultative Cardiology Practice

Coronary CT Angiography to Guide PCI: #CT4PCI

A discussion on the use of CCTA in PCI planning and its evolving role in patient care.

Yader Sandoval

MD, FACC, FSCAI, FESC

Interventional Cardiologist and Co-Chairman, Center for Coronary Artery Disease, Minneapolis Heart Institute

Diagnostic and Prognostic Implications of Cleerly AI-QCT

An exploration of how Cleerly AI-QCT provides insights into diagnosis and risk assessment.

Sarah Bär

Clinical Researcher, Cardiologist, Fellow Interventional Cardiology

Top Ten Questions: Understanding the Value and Benefits of AI-Based Plaque and Ischemia Analysis